A new RSV shot could help protect babies this winter — if they can get it in time

Nirsevimab is approved for all infants up to 8 months old, and for some older babies and toddlers considered at higher risk of severe illness from RSV. The American Academy of Pediatrics recommends that every baby whose mother did not get the RSV vaccine while pregnant receive nirsevimab in the first week of life.

Related Keywords

Washington ,District Of Columbia ,United States ,Vancouver ,British Columbia ,Canada ,Alaska ,Oregon ,Colorado ,American ,Katie Sharff ,Ben Hoffman ,Mimi Luther ,Kate Brown ,Emily Bendt ,Eddie Frothingham ,Sean Oleary ,Samaritan Health Services ,Centers For Disease ,Astrazeneca ,American Academy Of Pediatrics ,Pfizer ,University Of Colorado School Medicine ,Disease Control ,American Academy ,Kaiser Permanente ,Oregon Health ,Science University ,Doernbecher Children ,Seano Leary ,Colorado School ,Affordable Care Act ,Alaska Native ,American Indian ,Mid Valley Children ,Health Services ,